The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.
Principal Investigator(s)
Dougherty, Donald M
Funded by
NIH-ALCOHOL ABUSE & ALCOHOLISM
Collaborating Institutions
UMB
This renewal extends our work during the last award period and seeks to translate these findings to thecriminal justice system. Our accomplishments include: (a) developing methods for processing transdermalalcohol concentration data that yield clinically-meaningful quantification of drinking; (b) demonstratingcontingency management can be successfully implemented using transdermal alcohol monitors and thatcontingency management can produce sustained reductions in heavy drinking in non-treatment-seekingproblematic drinkers; and (c) establishing collaborations within the judicial system.
The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.
Principal Investigator(s)
Demeler, Borries
Funded by
NIH-GENERAL MEDICAL SCIENCES
We propose to continue development and support for the UltraScan-III (US3) software suite, acomprehensive toolkit for the analysis of data from hydrodynamic experiments and hydrodynamicsimulations. Such experiments include analytical ultracentrifugation, small angle X-ray and neutronscattering experiments, as well as bead model simulations. Support for this project will assure futureavailability of a mature multi-platform analysis suite with important and unique capabilities not found inany other software packages.
The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.
Principal Investigator(s)
Woods, James H
Funded by
NIH-NATL INSTITUTE OF MENTAL HEALTH
Collaborating Institutions
UMB MICHIGAN MCLEAN
The recent reports that scopolamine has antidepressant effects in humans has raised the hope that this antimuscarinic drug represents an improvement over the serotonergic and noradrenergic reuptake blockers that have formed the basis for antidepressant medication for decades. Scopolamine's effects had a rapid onset of action, and were quite long lasting, giving them considerable advantage over previous medications.
The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.
Principal Investigator(s)
Dougherty, Donald M
Funded by
NIH-ALCOHOL ABUSE & ALCOHOLISM
Collaborating Institutions
UMB
This renewal extends our work during the last award period and seeks to translate these findings to thecriminal justice system. Our accomplishments include: (a) developing methods for processing transdermalalcohol concentration data that yield clinically-meaningful quantification of drinking; (b) demonstratingcontingency management can be successfully implemented using transdermal alcohol monitors and thatcontingency management can produce sustained reductions in heavy drinking in non-treatment-seekingproblematic drinkers; and (c) establishing collaborations within the judicial system.
The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.
Principal Investigator(s)
Demeler, Borries
Funded by
NIH-GENERAL MEDICAL SCIENCES
We propose to continue development and support for the UltraScan-III (US3) software suite, acomprehensive toolkit for the analysis of data from hydrodynamic experiments and hydrodynamicsimulations. Such experiments include analytical ultracentrifugation, small angle X-ray and neutronscattering experiments, as well as bead model simulations. Support for this project will assure futureavailability of a mature multi-platform analysis suite with important and unique capabilities not found inany other software packages.
The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.
Principal Investigator(s)
Woods, James H
Funded by
NIH-NATL INSTITUTE OF MENTAL HEALTH
Collaborating Institutions
UMB MICHIGAN MCLEAN
The recent reports that scopolamine has antidepressant effects in humans has raised the hope that this antimuscarinic drug represents an improvement over the serotonergic and noradrenergic reuptake blockers that have formed the basis for antidepressant medication for decades. Scopolamine's effects had a rapid onset of action, and were quite long lasting, giving them considerable advantage over previous medications.